ShellStockReview.com

Member Login

Forum - Latest Posts

  • No posts to display.
Welcome, Guest
Username: Password: Remember me

TOPIC: AMXT (AAXT) just started filing again. may be a very nice shell

AMXT (AAXT) just started filing again. may be a very nice shell 11 years 1 month ago #1348

  • Guest
  • Guest's Avatar
[AAXT super 8K out...]
The Super 8K had more details about the new company:

Some highlights:

- Shanghai Medical is in the business of distributing and selling hemodialysis equipment (“HDE”) and related products and services, including disposable products used in hemodialysis (“Disposables”). Its principal product is HDE, which is mainly used by hospitals and other medical facilities. Shanghai Medical is the distributor of HDE manufactured by Fresenius Medical Care AG (“Fresenius”) in Shanghai and other parts of Eastern China. Fresenius is the largest manufacturer of HDE in the world and its products enjoy the largest share of the PRC market, as well as the U.S. market. We believe that Shanghai Medical has the largest share of the HDE distribution market in the PRC. Shanghai Medical also provides consulting services regarding product registration and clinical trials, hardware and facility operations for its customers and logistics regarding Pharmaceuticals, Disposables and other supplies and has a minority interest in a PRC manufacturer of Disposables. We plan to expand Shanghai Medical’s business both geographically and vertically, expanding its distribution territory, widening its products and developing its own kidney treatment centers in the PRC.

- Under the Securities Purchase Agreement among the Company and the Investors (the “Securities Purchase Agreement”), on April 15, 2008, for a total purchase price of $12,532,000, we sold to the Investors listed in Exhibit A to the Securities Purchase Agreement. a total of 4,008,188 shares of our Series A Preferred.


- Our strategy is two-fold:
First, we are planning to expand our geographic reach within the PRC by expanding our distribution channels through a traditional Western-style marketing plan into the main commercial markets in China, including, but not limited to, the Pearl River Delta, Beijing and other first tier markets in Eastern China. We believe that this development will be enhanced by recent National Medical Reform within the PRC creating a national healthcare system which we anticipate can allow for a substantial increase in hemodialysis treatments within the PRC over the next decade.

Second, we are planning to expand our business vertically in the hemodialysis field. Currently, we own 20% of a domestic manufacturer of disposable supplies for hemodialysis and plan to expand our presence within production of both equipment and supplies. Disposable supplies are the tubing filters and other disposable items necessary with each hemodialysis treatment. In addition to our current channels, we are intend to launch a chain of diagnostic and treatment centers in the PRC similar to those found in America and other Western nations.

- Net revenues were $34,966,210 for the fiscal year ended December 31, 2007, an increase of $10,873,710 or 45.13% from $24,092,500 for the fiscal year ended December 31, 2006.

- Net income was $7,227,560 for the fiscal year ended December 31, 2007, an increase of $1,144,372 or 18.81% from $6,083,188 for the fiscal year ended December 31, 2006. Net profit margin was 20.67 % for the fiscal year ended December 31, 2007 compared to 25.25 % for the same period in 2006 because the increase in our expenses in expanding our sales, and in restructuring management to meet the requirements of an expanding enterprise, was larger than the increase in sales.

- Chen Zhong, our Chairman, Chief Executive Officer and a director since April 15, 2008 has been Chairman of the Board, CEO and a director of Shanghai Medical Company Limited (“Shanghai Medical”) since 2005. Shanghai Medical is an affiliate of Kamick and ABM. Mr. Chen was President of Shanghai Pharm & Hemo-Tech International Co., Ltd. from 2002 to 2007. Mr. Chen has 16 years’ experience in the management of international pharmaceutical companies. He earned a Bachelors degree from East China Industrial University in Shanghai in 1989. He also was awarded a graduate degree in Economics from the Shanghai Fudan University in 2005.

www.sec.gov/Archives/edgar/data/1358940/...23370/v111064_8k.htm
The administrator has disabled public write access.

AMXT (AAXT) just started filing again. may be a very nice shell 11 years 2 months ago #1343

  • Guest
  • Guest's Avatar
[AAXT and Shanghai Medical Technology Co. Ltd.]
This is about all I could find on the new company...

Shanghai Medical is a provider of high quality disposable products and related services to support medical equipment in the field of blood and blood related elements. It virtually stands alone in its field in China's largest commercial market, Shanghai.

CLIENT LIST: The Company's existing client list includes every major hospital, blood bank and diagnostic center in Shanghai.

PARTNERSHIPS: Shanghai Medical has strategically partnered with the largest global providers of blood dialysis and diagnostic equipment, Roche and Fresenius (NYSE: FMS), to ensure that its growth will parallel the industry's as China's consumption of healthcare products grows.

NATIONAL HEALTHCARE: Currently in China the market for the Company's existing product line is approximately $375 million. Recent PRC policy expansion will see an available market increase of 5 to 10 fold over the next 5 to 8 years.

yaya214.vicp.net/index.asp
The administrator has disabled public write access.

AMXT (AAXT) just started filing again. may be a very nice shell 11 years 2 months ago #1342

  • Guest
  • Guest's Avatar
[AAXT reverse merger with Shanghai Medical Technology Co. Ltd.]
Our Profile List stock Aamaxan Transport Group Inc. issued an SC14F1 announcing they will effectively acquire the assets and business of Shanghai Medical Technology Co. Ltd., a company organized under the laws of the People’s Republic of China, that is in the business of distributing and selling hemodyalisis equipment and related products and services, including disposible products used in hemodyalysis, diagnostic products and consulting services:
The administrator has disabled public write access.

AMXT (AAXT) just started filing again. may be a very nice shell 12 years 2 weeks ago #1200

  • Guest
  • Guest's Avatar
[Re: AMXT just started filing again. may be a very nice shell]
AMXT getting some attention lately
The administrator has disabled public write access.

AMXT (AAXT) just started filing again. may be a very nice shell 12 years 2 months ago #1174

  • Guest
  • Guest's Avatar
[AMXT - Shell Stock - now on otcbb exchange]
clean, moving up. just listed on the otcbb also:

otcbb.com/asp/dailylist_detail.asp?mkt_ctg=OTCBB&d=04/10/2007
The administrator has disabled public write access.

AMXT (AAXT) just started filing again. may be a very nice shell 13 years 2 months ago #961

  • Guest
  • Guest's Avatar
[AMXT (AAXT) just started filing again. may be a very nice shell]
www.sec.gov/cgi-bin/browse-edgar?company...de&action=getcompany

www.sec.gov/Archives/edgar/data/1358940/...0285/aamaxan10sb.txt

www.sec.gov/Archives/edgar/data/1358940/...096906-06-000287.txt


Looks like a low float, with intent to get all the filings up to date and activate a merger with an active company. may be worthy of the list.

best regards and thank you for the forum.
The administrator has disabled public write access.
Moderators: Editor
Time to create page: 0.209 seconds